Most Read News

OCCRP is a network of investigative reporters supported by entities like the United States Department of State and George Soros.

IRM Energy's IPO aims to raise Rs 545.4 crore

This move was made to increase Dabur's business resiliency and control over its IT operations.

According to the International Diabetes Federation (IDF), the prevalence of diabetes in India is expected to increase to 125 million by 2045, of which 77% would have uncontrolled diabetes.

Although Aurobindo and Zydus are their preferred picks from the US-focused generic companies, their absolute top-picks in the sector include Sun Pharma, Mankind, JB Pharma and Alkem.

Q1FY24 results show 5.9% on-quarter net profit growth and 14.8% on-year rise to Rs 200 crore

The company's board of directors announced an interim dividend of Rs 17 per equity share

The Birla family and private investment vehicles currently hold a 37.9% stake valued at Rs 3,890 crore

Net premium income increased by 5% to Rs 10,022 crore in the reporting quarter compared to Rs 9,581 crore in the corresponding quarter last year.

Recommendation: Buy; Target price: Rs 9600